140 related articles for article (PubMed ID: 21560052)
1. The histone deacetylase inhibitor sodium butyrate in combination with brain-derived neurotrophic factor reduces the viability of DAOY human medulloblastoma cells.
Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
Childs Nerv Syst; 2011 Jun; 27(6):897-901. PubMed ID: 21560052
[TBL] [Abstract][Full Text] [Related]
2. Viability of D283 medulloblastoma cells treated with a histone deacetylase inhibitor combined with bombesin receptor antagonists.
Jaeger M; Ghisleni EC; Fratini L; Brunetto AL; Gregianin LJ; Brunetto AT; Schwartsmann G; de Farias CB; Roesler R
Childs Nerv Syst; 2016 Jan; 32(1):61-4. PubMed ID: 26590027
[TBL] [Abstract][Full Text] [Related]
3. Synergistic anti-cancer effects of epigenetic drugs on medulloblastoma cells.
Yuan J; Llamas Luceño N; Sander B; Golas MM
Cell Oncol (Dordr); 2017 Jun; 40(3):263-279. PubMed ID: 28429280
[TBL] [Abstract][Full Text] [Related]
4. The histone deacetylase inhibitor sodium butyrate promotes cell death and differentiation and reduces neurosphere formation in human medulloblastoma cells.
Nör C; Sassi FA; de Farias CB; Schwartsmann G; Abujamra AL; Lenz G; Brunetto AL; Roesler R
Mol Neurobiol; 2013 Dec; 48(3):533-43. PubMed ID: 23516101
[TBL] [Abstract][Full Text] [Related]
5. BDNF and PDE4, but not the GRPR, regulate viability of human medulloblastoma cells.
Schmidt AL; de Farias CB; Abujamra AL; Kapczinski F; Schwartsmann G; Brunetto AL; Roesler R
J Mol Neurosci; 2010 Mar; 40(3):303-10. PubMed ID: 19642024
[TBL] [Abstract][Full Text] [Related]
6. Valproic acid treatment response in vitro is determined by TP53 status in medulloblastoma.
Mascaro-Cordeiro B; Oliveira ID; Tesser-Gamba F; Pavon LF; Saba-Silva N; Cavalheiro S; Dastoli P; Toledo SRC
Childs Nerv Syst; 2018 Aug; 34(8):1497-1509. PubMed ID: 29785653
[TBL] [Abstract][Full Text] [Related]
7. HD-MB03 is a novel Group 3 medulloblastoma model demonstrating sensitivity to histone deacetylase inhibitor treatment.
Milde T; Lodrini M; Savelyeva L; Korshunov A; Kool M; Brueckner LM; Antunes AS; Oehme I; Pekrun A; Pfister SM; Kulozik AE; Witt O; Deubzer HE
J Neurooncol; 2012 Dec; 110(3):335-48. PubMed ID: 23054560
[TBL] [Abstract][Full Text] [Related]
8. Fingolimod (FTY720) reduces viability and survival and increases histone H3 acetylation in medulloblastoma cells.
Perla AS; Fratini L; Cardoso PS; de Farias CB; da Cunha Jaeger M; Roesler R
Pediatr Hematol Oncol; 2020 Mar; 37(2):170-175. PubMed ID: 31826690
[TBL] [Abstract][Full Text] [Related]
9. Histone deacetylase inhibitors induce cell death and enhance the susceptibility to ionizing radiation, etoposide, and TRAIL in medulloblastoma cells.
Sonnemann J; Kumar KS; Heesch S; Müller C; Hartwig C; Maass M; Bader P; Beck JF
Int J Oncol; 2006 Mar; 28(3):755-66. PubMed ID: 16465382
[TBL] [Abstract][Full Text] [Related]
10. Antiproliferation and radiosensitization of caffeic acid phenethyl ester on human medulloblastoma cells.
Lin YH; Chiu JH; Tseng WS; Wong TT; Chiou SH; Yen SH
Cancer Chemother Pharmacol; 2006 Apr; 57(4):525-32. PubMed ID: 16172905
[TBL] [Abstract][Full Text] [Related]
11. The effect of alpha-v integrin inhibition on the malignant characteristics of medulloblastoma.
Thompson EM; Whitney NL; Wu YJ; Neuwelt EA
J Neurosurg Pediatr; 2013 Jan; 11(1):60-7. PubMed ID: 23082872
[TBL] [Abstract][Full Text] [Related]
12. Histone deacetylase inhibitors induce medulloblastoma cell death independent of HDACs recruited in REST repression complexes.
Alshawli AS; Wurdak H; Wood IC; Ladbury JE
Mol Genet Genomic Med; 2020 Oct; 8(10):e1429. PubMed ID: 32720471
[TBL] [Abstract][Full Text] [Related]
13. Triptolide inhibits the proliferation and migration of medulloblastoma Daoy cells by upregulation of microRNA-138.
Zhang H; Li H; Liu Z; Ge A; Guo E; Liu S; Chen Z
J Cell Biochem; 2018 Dec; 119(12):9866-9877. PubMed ID: 30156009
[TBL] [Abstract][Full Text] [Related]
14. Valproic Acid prolongs survival time of severe combined immunodeficient mice bearing intracerebellar orthotopic medulloblastoma xenografts.
Shu Q; Antalffy B; Su JM; Adesina A; Ou CN; Pietsch T; Blaney SM; Lau CC; Li XN
Clin Cancer Res; 2006 Aug; 12(15):4687-94. PubMed ID: 16899619
[TBL] [Abstract][Full Text] [Related]
15. Successful Use of Dose Dense Neoadjuvant Chemotherapy and Sodium Valproate with Minimal Toxicity in an Infant with Medulloblastoma in Extremely Poor General Condition.
Gupta A; Kumar A; Abrari A; Patir R; Vaishya S
World Neurosurg; 2016 Sep; 93():485.e1-5. PubMed ID: 27450977
[TBL] [Abstract][Full Text] [Related]
16. In vitro and in vivo variation in transferrin receptor expression on a human medulloblastoma cell line.
Wen DY; Hall WA; Conrad J; Godal A; Flørenes VA; Fodstad O
Neurosurgery; 1995 Jun; 36(6):1158-63; discussion 1163-4. PubMed ID: 7643997
[TBL] [Abstract][Full Text] [Related]
17. Modulation of Viability, Proliferation, and Stemness by Rosmarinic Acid in Medulloblastoma Cells: Involvement of HDACs and EGFR.
Laschuk Herlinger A; Lovatto Michaelsen G; Sinigaglia M; Fratini L; Nogueira Debom G; Braganhol E; Brunetto de Farias C; Lunardi Brunetto A; Tesainer Brunetto A; da Cunha Jaeger M; Roesler R
Neuromolecular Med; 2023 Dec; 25(4):573-585. PubMed ID: 37740824
[TBL] [Abstract][Full Text] [Related]
18. Anti-EGFR therapy combined with neuromedin B receptor blockade induces the death of DAOY medulloblastoma cells.
Jaeger M; Nör C; de Farias CB; Abujamra AL; Schwartsmann G; Brunetto AL; Roesler R
Childs Nerv Syst; 2013 Dec; 29(12):2145-50. PubMed ID: 24092425
[TBL] [Abstract][Full Text] [Related]
19. Posttraining systemic administration of the histone deacetylase inhibitor sodium butyrate ameliorates aging-related memory decline in rats.
Reolon GK; Maurmann N; Werenicz A; Garcia VA; Schröder N; Wood MA; Roesler R
Behav Brain Res; 2011 Aug; 221(1):329-32. PubMed ID: 21421011
[TBL] [Abstract][Full Text] [Related]
20. Preferential sensitivity to HDAC inhibitors in tumors with CREBBP mutation.
Hellwig M; Merk DJ; Lutz B; Schüller U
Cancer Gene Ther; 2020 May; 27(5):294-300. PubMed ID: 31068675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]